NMT Medical, Inc. Sealed Bid Sale of its Intellectual Property to Take Place Friday, June 10, 2011 at Twelve O'Clock Noon

WELLESLEY HILLS, Massachusetts, May 10, 2011 - On Friday, June 10, 2011 at twelve o'clock noon, NMT Medical, Inc.
intellectual property, which has been assigned to Joseph F. Finn, Jr., C.P.A.
("Finn") of the firm Finn, Warnke & Gayton, LLP will be liquidated for the
benefit of NMT Medical creditors.

NMT Medical, Inc. was an advanced medical technology company that
designed, developed, manufactured and marketed proprietary implant
technologies that allowed interventional cardiologists to treat structural
heart disease through minimally invasive, catheter-based procedures. More
than 32,000 patients have been treated globally with its minimally invasive,
catheter-based implant technology.

The intellectual property, patents, etc. will be sold at a sealed bid
sale on Friday, June 10, 2011 at noon. Persons interested in bidding must
sign a Confidentiality Disclosure Agreement ("CDA") obtained from Finn's
Office - jffinnjr@finnwarnkegayton.com or +1-781-237-8840. They will then
receive a bid package.

About Joseph F. Finn, Jr., C.P.A.

Joseph F. Finn, Jr., C.P.A. is a founding partner of the firm Finn,
Warnke & Gayton (www.finnwarnkegayton.com), Certified Public
Accountants of Wellesley Hills, Massachusetts. He works primarily in the area
of management consulting for distressed enterprises, bankruptcy accounting
and related matters, such as assignee for the benefit of creditors and
liquidating agent for a corporation. He has been involved in a number of loan
workouts and bankruptcy cases for thirty-seven (37) years. His most recent
Assignments for the Benefit of Creditors in the biotech field include
Spherics, Inc., ActivBiotics, Inc., Prospect Therapeutics, Inc., EPIX
Pharmaceuticals, Inc. and Source MDx.

For further information, please contact Joseph F. Finn, Jr., C.P.A. at
+1-781-237-8840 or jffinnjr@finnwarnkegayton.com

.